Details

Product number
6572603
CPT
-
Packaging group
5 x 1875
Unit
ml
Composition
I) Glucoselösung: glucosum 270 g ut glucosum monohydricum 297 g, acidum citricum monohydricum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 750 ml. II) Fettemulsion: sojae oleum 30 g, triglycerida media 37.5 g, omega-3 acidorum triglycerida 7.5 g, glycerolum, lecithinum ex ovo, natrii oleas, natrii hydroxidum q.s. ad pH, E 307, aqua ad iniectabile q.s. ad emulsionem pro 375 ml. III) Aminosäurelösung: isoleucinum 6.15 g, leucinum 8.22 g, lysinum anhydricum 5.97 g ut lysinum monohydricum 6.71 g, methioninum 5.13 g, phenylalaninum 9.22 g, threoninum 4.76 g, tryptophanum 1.5 g, valinum 6.76 g, argininum 7.087 g, histidinum 3.285 g, alaninum 12.735 g, acidum asparticum 3.937 g, acidum glutamicum 9.202 g, glycinum 4.335 g, prolinum 8.925 g, serinum 7.875 g, acidum citricum monohydricum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 750 ml. I) et II) et III) corresp.: aminoacida 56 g/l, nitrogenia 8 g/l, carbohydrata 144 g/l, materia crassa 40 g/l, in emulsione recenter mixta, Corresp. 4940 kJ pro 1 l.

Articles (1)

Omegaflex special ohne Elektrolyte, Emulsion zur Infusion 1875 ml
Emulsion
5 x 1875
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
29/04/2025
Professional SmPC
Français
29/04/2025
Professional SmPC
Italien
29/04/2025

Detailed composition

Substance Quantity Type Category
aminoacida
56.0 GL Substance Wirkstoff (Principe actif)
isoleucinum
6.15 G Substance Wirkstoff (Principe actif)
sojae oleum
30.0 G Substance Wirkstoff (Principe actif)
glucosum
270.0 G Substance Wirkstoff (Principe actif)
triglycerida media
37.5 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
297.0 G Substance WIZUS
nitrogenia
8.0 GL Substance Wirkstoff (Principe actif)
leucinum
8.22 G Substance Wirkstoff (Principe actif)
carbohydrata
144.0 GL Substance Wirkstoff (Principe actif)
omega-3 acidorum triglycerida
7.5 G Substance Wirkstoff (Principe actif)
lysinum anhydricum
5.97 G Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
materia crassa
40.0 GL Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
lysinum monohydricum
6.71 G Substance WIZUS
aqua ad iniectabile
- Substance HNIDK
methioninum
5.13 G Substance Wirkstoff (Principe actif)
lecithinum ex ovo
- Substance HNIDK
phenylalaninum
9.22 G Substance Wirkstoff (Principe actif)
natrii oleas
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
threoninum
4.76 G Substance Wirkstoff (Principe actif)
tryptophanum
1.5 G Substance Wirkstoff (Principe actif)
E 307
- Substance ANTON
aqua ad iniectabile
- Substance HNIDK
valinum
6.76 G Substance Wirkstoff (Principe actif)
argininum
7.087 G Substance Wirkstoff (Principe actif)
histidinum
3.285 G Substance Wirkstoff (Principe actif)
alaninum
12.735 G Substance Wirkstoff (Principe actif)
acidum asparticum
3.937 G Substance Wirkstoff (Principe actif)
acidum glutamicum
9.202 G Substance Wirkstoff (Principe actif)
glycinum
4.335 G Substance Wirkstoff (Principe actif)
prolinum
8.925 G Substance Wirkstoff (Principe actif)
serinum
7.875 G Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

B. Braun Medical AG

6204 Sempach

Authorization information

Swissmedic authorization number
65726
Drug name
Omegaflex special ohne Elektrolyte, Emulsion zur Infusion
Galenic form
EMUI
ATC Code
B05BA10
Authorization status
Z
Dispensation category
B
First authorization
07/02/2017
Authorization expiration date
31/12/9999
IT number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung

Packaging details

Description (FR)
OMEGAFLEX spe s.élec émuls perf 1875ml sach 5 pce
Description (DE)
OMEGAFLEX spec o. Elek Inf Emuls 1875ml Btl 5 Stk
Market launch
07/02/2017
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data